Periodontal disease is a common, chronic inflammatory condition and has a multifactorial etiology, with primary etiological agents being pathogenic bacteria in the subgingival area. The standard periodontal therapy is with the objective of reducing the total bacterial load and changing the environmental conditions of the microbial niches. Although mechanical debridement (scaling and root planing \[SRP\]) reduces the level of subgingival bacteria, it does not eliminate all the pathogens which reside deep in connective tissue which destroys the bone.\[[@ref1]\]

To overcome the limitations of this conventional treatment, chemical agents such as antibiotics and antiseptics have been used successfully to treat moderate to severe periodontal diseases.\[[@ref2]\] For the shortcomings of systemic administration such as bacterial resistance and drug interactions, local delivery systems containing antibiotic or antiseptic agents were introduced.\[[@ref3]\] Various locally delivered agents that are successfully used include tetracycline fibers,\[[@ref4]\] 10% doxycycline,\[[@ref5][@ref6]\] 2% minocycline,\[[@ref7]\] metronidazole,\[[@ref8]\] and chlorhexidine gluconate,\[[@ref9]\] but none is without side effects. Research is being conducted for the use of the natural products instead of chemical agents. Medicinal plants have been used as a traditional treatment agent for numerous human diseases since ages in many parts of the world. One such natural product which holds medicinal value is turmeric (*Curcuma longa*).\[[@ref10]\]

Curcumin has proven properties such as anti-inflammatory, antioxidant, antimicrobial, hepatoprotective, immunostimulant, antiseptic, antimutagenic, and it also accelerates wound healing.\[[@ref11]\] Curcumin is the principal curcuminoid of the popular Indian spice turmeric, which is a member of the ginger family (*Zingiberaceae*). The other two curcuminoids are desmethoxycurcumin and bisdemethoxycurcumin.\[[@ref12]\] Reactive oxygen species (ROS) include oxygen-derived free radicals, such as superoxide (O~2~−), hydroxyl (OH), nitric oxide, hydrogen peroxide, and hypochlorous acid (HOCl). This oxidative stress phenomenon is believed in part to be responsible for the inflammatory conditions affecting the periodontium, manifesting as gingivitis and periodontitis.

The purpose of this study was to investigate the level of superoxide dismutase (SOD) enzyme, in gingival crevicular fluid (GCF), and the impact of nonsurgical treatment on the antioxidant profile using 0.2% curcumin strip as local drug delivery.

Materials and Methods {#sec1-1}
=====================

A randomized split mouth-controlled clinical study was conducted to evaluate the effectiveness of curcumin strip in the treatment of chronic periodontitis compared to SRP alone. The protocol was reviewed and approved by the Institutional Ethical Board. The study-related procedures were explained to the patients before they signed an informed consent form. A total of twenty subjects of age 35--55 years and 15 subjects with chronic periodontitis, each with bilateral 5--6 mm probing pocket depth (PPD), were recruited from the outpatient Department of Periodontics, J.K.K. Nattraja Dental College and Hospital, Komarapalayam, Tamil Nadu, India. Patients who received treatment with any form of antibiotics/anti-inflammatory drugs in the last 3 months, smokers, and with history of systemic diseases, pregnancy, lactation, and drug allergies were excluded from this study. A composition of 0.2% curcumin was loaded onto the guided tissue regeneration (GTR) membrane (Heali Guide -- Advanced Biotechnology) and was used in strip form as shown in [Figure 1](#F1){ref-type="fig"}. Preoperative probing depth was measured and gcf sample was collected preoperatively as shown in Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"} respectively.

![0.2% loaded curcumin strip](JPBS-8-48-g001){#F1}

![Preoperative (probing pocket depth mm)](JPBS-8-48-g002){#F2}

![Gingival crevicular fluid collection. (a) Control group, (b) Test group](JPBS-8-48-g003){#F3}

Criteria for grouping {#sec2-1}
---------------------

Healthy group: It consists of 5 sites in which no bleeding on probing, no pocket depth (Healthy group)Group I: It consists of 15 sites, in which SRP was done (control group)Group II: It consists of 15 sites, in which SRP was followed by the placement of curcumin strip inside the pocket (SRP + curcumin strip) (test group) as shown in [Figure 4](#F4){ref-type="fig"}.

![Curcumin strip placement](JPBS-8-48-g004){#F4}

GCF collection was done using micropipettes preoperatively and postoperatively after 21 days as shown in [Figure 3](#F3){ref-type="fig"}. Postoperative probing depth was measured as shown in [Figure 5](#F5){ref-type="fig"}. The SOD activity was assessed using enzyme-linked immunosorbent assay as shown in Figures [6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}. The clinical parameters such as plaque index (PI), gingival index (GI), and sulcus bleeding index (SBI) were assessed at baseline and on the 21^st^ day.

![Postoperative (probing pocket depth mm)](JPBS-8-48-g005){#F5}

![Laboratory analysis](JPBS-8-48-g006){#F6}

![Results of enzyme-linked immunosorbent assay](JPBS-8-48-g007){#F7}

Results {#sec1-2}
=======

The results obtained were analyzed statistically, and comparisons were made within each group using paired and unpaired Student\'s *t*-test using (IBM Corp. Released 2010. IBM SPSS Statistics for Windows, Version 19.0. Armonk, NY: IBM Corp). A value of *P* \< 0.05 was considered as the level of significance. The *in vitro* release of curcumin from the collagen membrane was over 24 h as shown in [Graph 1](#F8){ref-type="fig"}.

![The *in vitro* release of curcumin from the collagen membrane over 24 h](JPBS-8-48-g008){#F8}

The PI, GI, and SBI scores at baseline was 1.862 ± 0.539, 1.885 ± 0.595, 2.027 ± 0.444, respectively, and after 21 days, PI, GI, and SBI scores were reduced to 1.170 ± 0.192, 1.160 ± 0.239, 1.186 ± 0.212, respectively, as shown in [Table 1](#T1){ref-type="table"} and [Graph 2](#F9){ref-type="fig"}. Comparison of the PI, GI, and SBI scores between baseline and after 21 days shows a statistically significant difference with a *P* \< 0.05 in both test and control groups.

###### 

Comparison of clinical parameters at baseline and after 21 days

![](JPBS-8-48-g009)

![Comparison of mean changes in clinical parameters at baseline and on the 21^st^ day](JPBS-8-48-g010){#F9}

The PPD in Group I at baseline was 5.0 ± 0.0 mm, and the PPD after 21 days reduced to 2.467 ± 0.833 mm. The PPD in Group II at baseline was 5.0 ± 0.0 mm, and the PPD after 21 days reduced to 2.400 ± 0.828 mm. Comparison of the PPD in Groups I and II shows that statistically, there is no significant difference with a *P* \> 0.05 as shown in [Table 2](#T2){ref-type="table"} and [Graph 3](#F10){ref-type="fig"}.

###### 

Comparison of probing pocket depth between Group I and Group II

![](JPBS-8-48-g011)

![Intergroup comparison of mean changes of probing pocket depth in Groups I and II](JPBS-8-48-g012){#F10}

In the healthy group, the mean concentration of SOD levels was 12.264 ± 2.130. In the control group, at baseline, the SOD level was 1.448 ± 0.625 and 21 days after treatment SOD level improved to 9.366 ± 2.609. In the test group, the SOD level at baseline was 1.618 ± 0.746 and 21 days after treatment SOD level improved to 11.649 ± 2.884 as shown in [Table 3](#T3){ref-type="table"} and [Graph 4](#F11){ref-type="fig"}. Comparison of SOD levels postoperatively in both groups showed that there is a statistically significant difference with a *P* \< 0.05.

###### 

Comparison of superoxide dismutase levels between groups

![](JPBS-8-48-g013)

![Intergroup comparison of superoxide dismutase enzyme levels](JPBS-8-48-g014){#F11}

Discussion {#sec1-3}
==========

Periodontal disease is a multifactorial disease caused by microbial flora, which is present in the subgingival plaque. These bacterial species result in the production of various cytokines and also causes an increase in number and activity of polymorphonucleocytes (PMNs). PMNs produce ROS superoxide via the respiratory burst mechanism. ROS have deleterious effects on tissue cells when produced in excess.

Curcumin is a yellow pigment from *C. longa* and is a major component of turmeric.\[[@ref13]\] The desirable preventive or putative therapeutic properties of curcumin have also been considered to be associated with its antioxidant, anti-inflammatory, antimicrobial, and chemopreventive properties. The anti-inflammatory effect of curcumin is most likely mediated through its ability to inhibit cyclooxygenase-2, lipoxygenase, and inducible nitric oxide synthase. Curcumin may function indirectly as an antioxidant either by inhibiting the activity of inflammatory enzymes or by enhancing the synthesis of glutathione, an important intracellular antioxidant. Curcumin also acts as a free radical scavenger and antioxidant by inhibiting lipid peroxidation and oxidative DNA damage.\[[@ref14]\] Currently, there is a growing interest in the linkage between antioxidants and periodontal disease. A significant antioxidant enzyme within mammalian tissues is SOD, which catalyzes the dismutation of O~2~^−^ to H~2~O~2~ and O~2~.

Hence, curcumin possessing the antioxidant activity is used in this present study. Efficacy of 0.2% curcumin loaded onto the GTR membrane in strip form adjunct to SRP was evaluated in the present study. According to Franz diffusion method,\[[@ref15]\] maximum release of drug from strip used in this study was within 24 h.

In our present study, the clinical parameters such as PI, GI, and SBI scores were reduced from baseline to 21^st^ day in both test and the control groups. This is in accordance with the study conducted by Behal in 2001.\[[@ref11]\] The mean PPD was significantly reduced on the 21^st^ day compared to the baseline in both test and control groups. There is no significant difference between the control and test groups. The results were in accordance with the study conducted by Behal *et al*. in 2011,\[[@ref11]\] who demonstrated PPD reduction following placement of 2% turmeric gel, when compared to SRP alone.

GCF samples were taken at baseline and after SRP (21^st^ day). In the healthy group, SOD levels were 12.264 ± 2.130. In the control group, at baseline, SOD level was found to be 1.448 ± 0.625 and improved to 9.366 ± 2.609 on the 21^st^ day following periodontal therapy, which shows statistically significant differences before and after treatment in accordance with Karim *et al*. 2012.\[[@ref16]\] SOD level at baseline in the test group was 1.618 ± 0.746 and improved to 11.649 ± 2.884 on the 21^st^ day following periodontal therapy. On comparison of SOD levels, Group II showed statistically significant difference comparing to Group I. The SOD levels seem to be nearing to the healthy group when curcumin strip was used as an adjunct to SRP.

Summary and Conclusion {#sec1-4}
======================

From this study, all the clinical parameters were significantly reduced in test and control sites. Furthermore, SOD levels were significantly improved in test sites when compared with control sites. Thus, the present study concluded that curcumin strip can be effectively used as an adjunct to SRP in treatment of chronic periodontitis and serves as antioxidant in subgingival environment. Although the study has positive outcome for particular antioxidant, elaborate studies are needed to prove the efficacy of curcumin strip in other antioxidants and also with reference to areas such as proper concentration and release system.
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